Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04802356
Title Belantamab Mafodotin in Newly Diagnosed Transplant Eligible Multiple Myeloma Patients
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors PETHEMA Foundation
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP


No variant requirements are available.